Exhibit 10.11
March 5, 2018
Trisha Millican
VIA email
Trisha,
I am delighted to make you an offer of employment for the position of Chief Financial Officer (CFO) at Metacrine Inc. (the Company), reporting to Ken Song. The effective date of your employment will be based on a mutually acceptable date but no later than April 1, 2018. The terms of the offer are as follows:
Duties and Extent of Service
As full-time CFO for the Company, you will have responsibility for performing those duties as are customary for, and are consistent with, such position, as well as those duties as may be assigned to you from time to time. If you join the Company, you agree to abide by the rules, regulations, instructions, personnel practices and policies of the Company and any changes therein which may be adopted from time to time by the Company. Except for vacations and absences due to temporary illness, you will be expected to devote all of your business time and effort to the business and affairs of the Company.
Base Salary
The Company will pay you a base salary of 300,000 dollars per year, paid semimonthly, less payroll deductions, required taxes, withholdings and payable in accordance with the Company’s standard payroll practices.
Benefits
As a Company employee, your eligibility to participate in the Company employee benefit plans and fringe benefits will depend on whether you meet the eligibility terms of the applicable plans. In addition, you will be eligible to receive up to 30% of your annual salary in the form of a performance bonus each year, subject to approval of a bonus plan by the board of directors and in accordance with the terms of such approved plan.
Stock Options
In addition, if you decide to join the Company, it will be recommended to the Company’s Board of Directors following your start date that the Company grant you an option to purchase approximately 360,000 shares of the Company’s common stock at a price per share equal to the fair
METACRINE, INC.
12780 EL CAMINO REAL, SUITE 301
SAN DIEGO, CA 92130
market value per share of the Common Stock on the date of grant, as determined by the Company’s Board of Directors. 25% of the shares subject to the option shall vest 12 months after the date your vesting begins subject to your continuing employment with the Company, and no shares shall vest before such date. The remaining shares shall vest monthly over the next 36 months in equal monthly amounts subject to your continuing employment with the Company. This option grant will be subject to the terms and conditions of the Company’s equity incentive plan and stock option agreement, including vesting requirements. No right to any stock is earned or accrued until such time that vesting occurs, nor does the grant confer any right to continue vesting or employment.
Nondisclosure and Developments
The Company has extended this offer to you based upon your general knowledge, background, experience and skills and abilities and not because of your knowledge of your current employer’s or any previous employer’s trade secrets or other confidential information. As a condition of employment at the Company, you will be required to sign the Company’s standard At-Will Employment, Confidential Information, Invention Assignment and Arbitration Agreement in which you agree to, among other things, not disclose to the Company or use in your employment with the Company any confidential or proprietary information or trade secrets of any current or prior employer. In this regard, you should be extremely careful not to bring to the Company any documents or other materials in tangible form belonging to or acquired from any current or prior employer.
At-Will Employment
This Agreement is not a contract of employment for any specific or minimum term and that the employment the Company offers you is terminable at will. This means that our employment relationship is voluntary and based on mutual consent. You may resign your employment, and the Company likewise may terminate your employment, at any time, for any reason, with or without cause or notice. Any prior oral or written representations to the contrary are void, and any future representations to the contrary are also void and should not be relied upon unless they are contained in a formal written employment contract signed by an officer of the Company and expressly stating the company’s intent to modify the at-will nature of your employment.
Governing Law
This Agreement shall be governed by and construed in accordance with the internal substantive laws of the State of California.
Background Checks; Eligibility to Work in the United States
The Company reserves the right to conduct background investigations and/or reference checks on all of its potential employees. Your job offer, therefore, is contingent upon a clearance of such a background investigation and/or reference check, if any.
METACRINE, INC.
12780 EL CAMINO REAL, SUITE 301
SAN DIEGO, CA 92130
For purposes of federal immigration law, you will be required to provide to the Company documentary evidence of your identity and eligibility for employment in the United States. Such documentation must be provided to the Company within three (3) business days of your commencement date, or our employment relationship with you may be terminated.
Entire Agreement: Amendment
This Agreement will constitute the entire agreement and understanding between the Company and you with respect to the specific matters contemplated and addressed hereby. No prior agreement between you and the Company, whether written or oral, shall be construed to change or affect the operation of this Agreement in accordance with its terms, and any provision of any such prior agreement which conflicts with or contradicts any provision of this Agreement is hereby revoked and superseded.
This Agreement may be amended or modified only by a written instrument executed both by you and the Company. If any portion of this Agreement shall, for any reason, be held invalid or unenforceable, or contrary to public policy or any law, the remainder of this Agreement shall not be affected by such invalidity or unenforceability, but shall remain in full force and effect as if the invalid or unenforceable term or portion thereof had not existed within this Agreement.
This Agreement will expire if not accepted by March 9, 2018.
We are excited to have you on the team!
Sincerely, |
/s/ Ken Song |
Ken Song |
President & Chief Executive Officer |
Accepted By: /s/ Trisha Millican | ||
Print Name Trisha Millican | ||
Date March 6, 2018 | ||
METACRINE, INC.
12780 EL CAMINO REAL, SUITE 301
SAN DIEGO, CA 92130